Basic research as a prerequisite for novel therapeutic strategies in atrial fibrillation;Grundlagenforschung ist eine voraussetzung für innovative pharmakologische therapieansätze bei vorhofflimmern

Medizinische Welt

Volumn 58, Issue 4, 2007, Pages 131-134

  Kääb, Stefan ^a   Schotten, U ^b,c   Dobrev, D ^d   Kirchhof, P ^e   Ravens, U ^d   Goette, A ^f  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f Klinik fur Kardiologie Angiologie und Pneumologie   (Germany)

Author keywords

Atrial fibrillation; Pathophysiology; Remodeling; Treatment

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; PLACEBO; RSD 1235;

ARTICLE; CARDIOVERSION; CLINICAL COMPETENCE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE REGISTRY; HEART ATRIUM FIBRILLATION; HEART PROTECTION; HUMAN; MEDICAL SOCIETY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SOCIOECONOMICS;

EID: 34249044818     PISSN: 00258512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)